{"sourcedb":"DevicePMAs@therightstef","sourceid":"P120021_S000","text":"Approval for the AMPLATZER PFO Occluder.  The device is indicated for percutaneous transcatheter closure of a patent foramen ovale (PFO) to reduce the risk of recurrent ischemic stroke in patients, predominantly between the ages of 18 and 60 years, who have had a cryptogenic stroke due to a presumed paradoxical embolism, as determined by a neurologist and cardiologist following an evaluation to exclude known causes of ischemic stroke.","project":"consensus_PMA_Age_Indications","denotations":[{"id":"T4","span":{"begin":242,"end":247},"obj":"age_end_unit"},{"id":"T3","span":{"begin":239,"end":241},"obj":"age_end"},{"id":"T2","span":{"begin":232,"end":234},"obj":"age_start"},{"id":"T1","span":{"begin":232,"end":247},"obj":"age_range"}]}